Marshall Wace’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $181K | Buy |
+40,181
| New | +$181K | ﹤0.01% | 2331 |
|
|
2025
Q1 | – | Sell |
-49,225
| Closed | -$385K | – | 2969 |
|
|
2024
Q4 | $385K | Buy |
49,225
+33,716
| +217% | +$264K | ﹤0.01% | 1998 |
|
|
2024
Q3 | $204K | Buy |
+15,509
| New | +$204K | ﹤0.01% | 2125 |
|
|
2024
Q1 | – | Sell |
-114,786
| Closed | -$783K | – | 2526 |
|
|
2023
Q4 | $783K | Buy |
114,786
+15,855
| +16% | +$108K | ﹤0.01% | 1293 |
|
|
2023
Q3 | $539K | Sell |
98,931
-28,737
| -23% | -$157K | ﹤0.01% | 1424 |
|
|
2023
Q2 | $867K | Buy |
+127,668
| New | +$867K | ﹤0.01% | 1414 |
|
|
2022
Q4 | – | Sell |
-20,470
| Closed | -$295K | – | 2903 |
|
|
2022
Q3 | $295K | Buy |
+20,470
| New | +$295K | ﹤0.01% | 2237 |
|
|
2021
Q3 | – | Sell |
-12,310
| Closed | -$415K | – | 2896 |
|
|
2021
Q2 | $415K | Buy |
+12,310
| New | +$415K | ﹤0.01% | 1734 |
|
|
2019
Q4 | – | Sell |
-1,100
| Closed | -$29K | – | 2064 |
|
|
2019
Q3 | $29K | Buy |
+1,100
| New | +$29K | ﹤0.01% | 1529 |
|